Additional Information:
http://foundationcenter.org/pnd/rfp/rfp_item.jhtml?id=429000049
Description:
The American Diabetes
Association, with support from Eli Lilly and
Company, is inviting applications for original and innovative translational
and clinical research proposals focused on improving the evidence base and
understanding of the goals, barriers, and effects of treatments and
interventions (beneficial and adverse) in older adults with both type 1 and type
2 diabetes.
The aim of the initiative is to further identify the safest and most
effective means of diabetes treatment for this population.
Translational and clinical research projects will receive a maximum of
$550,000 over three years (no more than $200,000 per year in any one year,
including indirect costs).
To be eligible, applicants must hold a Ph.D., M.D., Pharm.D., D.P.M., or
equivalent health- or science-related degree. In addition, applicants must hold
full-time faculty positions or the equivalent at university-affiliated
institutions or other nonprofit research and clinical institutions within the
United States or one of its territories.
See the ADA Web site for complete program information and application
guidelines.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.